
CAPHRA Calls For Evidence-Based Approach In Tobacco Control Policies
Nancy Loucas, Executive Coordinator of CAPHRA, commented, 'Public health policy is most effective when grounded in robust scientific evidence. When decisions are influenced by politics or other non-scientific factors, there is a risk of undermining public trust and missing opportunities to reduce preventable harm.'
CAPHRA's recent analysis of global tobacco control efforts points to ongoing challenges in incorporating diverse perspectives into the policymaking process. The organisation noted that during the recent COP10 summit, several harm reduction advocates were not permitted to present evidence on smoke-free alternatives despite growing data supporting their role in helping adults reduce or quit smoking.
'There is a need for greater inclusivity in discussions on tobacco harm reduction,' said Clarisse Virgino, CAPHRA Philippines representative. 'Ensuring that policy reflects current evidence, including independent studies and lived experience, is vital for balanced and effective regulation.'
CAPHRA also responded to the World Health Organization's 2025 theme, 'Unmasking Industry Tactics,' expressing concern that conflating consumer advocacy with industry lobbying can hinder meaningful dialogue. The group cited data indicating that an estimated 82 million people globally use vaping as a means of remaining tobacco-free.
In the Asia Pacific region, CAPHRA observed inconsistencies between stated public health goals and policy actions. 'It's important that regulatory strategies align with public health objectives and are implemented transparently,' Loucas noted. CAPHRA recommends that countries consider models like that of the United Kingdom, which involves strict regulation of safer nicotine products (SNPs), public education, and the inclusion of consumer input in policy development.
'The global tobacco control effort is evolving, and a fact-based, risk-proportionate approach can contribute meaningfully to reducing tobacco-related disease and death,' Virgino concluded.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Scoop
2 days ago
- Scoop
Vaping Risks Overstated: CAPHRA Calls For Science, Not Scare Tactics
In response to the article published by The Sun Malaysia titled 'Many harmful chemicals found in vape liquids', CAPHRA welcomes continued scrutiny of all nicotine delivery systems. However, it is essential that reporting is balanced, evidence-based, and accurately contextualized. Firstly, identifying thousands of compounds in vape aerosols is not unexpected. Modern laboratory analysis can detect trace chemicals at parts-per-billion levels—many of which are not proven to be harmful at the concentrations used in legal, regulated nicotine e liquids. According to Samsul Arrifin Kamal, of MOVE Malaysia 'Presence does not equate to risk, and suggesting otherwise misrepresents scientific principles.' Critically, no credible study to date has shown that vaping is more harmful than smoking. In fact, leading independent reviews—including those by Public Health England and the UK Office for Health Improvement and Disparities—consistently conclude that vaping is significantly less harmful than combustible tobacco. Unlike cigarette smoke, which contains over 7,000 chemicals including dozens of known carcinogens, vape aerosols contain far fewer and at much lower levels. Concerns about metals and volatile compounds should be addressed through proper regulation, not fear. Poorly manufactured or illicit devices pose real risks—this is why Malaysia's reintroduction of the Control of Smoking Products for Public Health Act (Act 852) was a necessary step. Enforcing product quality, ingredient transparency, and sales restrictions is the path forward. The public deserves clear, science-led communication. Overstating the dangers of vaping can have unintended consequences by discouraging adults who smoke from switching to safer alternatives, or pushing vapers back to combustible tobacco. Kamal further states, 'In short, vaping is not risk-free and should not be marketed to youth. But for adult smokers unable to quit nicotine entirely, switching to regulated vaping products remains a significantly less harmful choice.' We urge policymakers, the media, and the public to focus on proportional regulation, product safety enforcement, and honest harm communication.


Scoop
17-07-2025
- Scoop
New Zealand Following International Success With Proven Harm Reduction
The Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA) welcomes New Zealand's forward-thinking decision to include oral nicotine products as part of its strategy to remain a global leader in achieving a smokefree future. As Professor Robert Beaglehole noted in the NZ Herald on 11 July 'Vaping has helped many – but it's not a silver bullet. We should also consider legalising and regulating synthetic-nicotine pouches, regarded as among the safest alternative products. Already available via the black market, bringing them under regulation would allow for quality control, responsible marketing, and youth safeguards.' Nancy Loucas, Executive Coordinator of CAPHRA, said, 'New Zealand has shown the world what's possible when governments trust science over ideology. Including oral nicotine products in the harm reduction toolkit recognises what Sweden has already proven—these products are particularly effective for people who have struggled with traditional quitting methods.' International experience, especially from Sweden, shows that oral nicotine pouches have helped accelerate smoking declines, particularly among women, who have seen quit rates rise dramatically. Research indicates that nicotine pouches outperform other quit aids, offering a safer, more socially acceptable, and environmentally friendly alternative to cigarettes. In the latest Eurobarometer Report, countries such as Greece and Czechia have also greatly benefitted from the regulation and availability of oral nicotine pouches. While some anti-tobacco activists still favour prohibition, evidence from around the world shows that countries embracing harm reduction see smoking rates drop much faster. 'The pattern is unmistakable: providing alternatives alongside traditional measures delivers the best results. We must not let ideology prevent access to life-saving innovations,' Loucas emphasised. Oral nicotine products are another vital tool in the smokefree toolbox. Just as New Zealand's embrace of vaping alongside traditional cessation methods delivered unprecedented results, oral nicotine products will ensure every smoker has access to the method that works best for them. CAPHRA commends this government's leadership in continuing to explore comprehensive tobacco harm reduction and supports New Zealand's continued evolution as a global leader in evidence-based tobacco control.


Scoop
06-07-2025
- Scoop
CAPHRA Calls For Evidence-Based Approach In Tobacco Control Policies
The Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA) is encouraging governments and international bodies to prioritise science and evidence in public health policymaking related to tobacco control and nicotine use. Nancy Loucas, Executive Coordinator of CAPHRA, commented, 'Public health policy is most effective when grounded in robust scientific evidence. When decisions are influenced by politics or other non-scientific factors, there is a risk of undermining public trust and missing opportunities to reduce preventable harm.' CAPHRA's recent analysis of global tobacco control efforts points to ongoing challenges in incorporating diverse perspectives into the policymaking process. The organisation noted that during the recent COP10 summit, several harm reduction advocates were not permitted to present evidence on smoke-free alternatives despite growing data supporting their role in helping adults reduce or quit smoking. 'There is a need for greater inclusivity in discussions on tobacco harm reduction,' said Clarisse Virgino, CAPHRA Philippines representative. 'Ensuring that policy reflects current evidence, including independent studies and lived experience, is vital for balanced and effective regulation.' CAPHRA also responded to the World Health Organization's 2025 theme, 'Unmasking Industry Tactics,' expressing concern that conflating consumer advocacy with industry lobbying can hinder meaningful dialogue. The group cited data indicating that an estimated 82 million people globally use vaping as a means of remaining tobacco-free. In the Asia Pacific region, CAPHRA observed inconsistencies between stated public health goals and policy actions. 'It's important that regulatory strategies align with public health objectives and are implemented transparently,' Loucas noted. CAPHRA recommends that countries consider models like that of the United Kingdom, which involves strict regulation of safer nicotine products (SNPs), public education, and the inclusion of consumer input in policy development. 'The global tobacco control effort is evolving, and a fact-based, risk-proportionate approach can contribute meaningfully to reducing tobacco-related disease and death,' Virgino concluded.